INTERNATIONAL PATENT: INNOVENT BIOLOGICS (SUZHOU) CO., LTD., 信达生物制药（苏州）有限公司 FILES APPLICATION FOR "ANTI-EGFR AND -HER3 BISPECIFIC ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, May 26 -- INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 信达生物制药（苏州）有限公司 (中国江苏省苏州市苏州工业园区东平街168号) filed a patent application (PCT/CN2024/131744) for "ANTI-EGFR AND -HER3 BISPECIFIC ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Nov 13, 2024. With publication no. WO/2025/103355, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, ...